Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00125749 · ClinicalTrials.gov registry record · Phase 1
Vaccination of Patients With Stage IV Melanoma With Dendritic Cells
A Phase 1 study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00125749: Completed Phase 1 study, sponsored by Baylor Research Institute.
NCT00125749 is a Phase 1 study that has completed, run by Baylor Research Institute. The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00125749, a Phase 1 study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to test a novel dendritic cell (DC) vaccine in patients with Stage IV melanoma.
Interventions
- BIOLOGICAL Dendritic cell vaccination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-07 |
| Est. Completion | 2007-06 |
| Phase | Phase 1 |
What the finished NCT00125749 record still lists
NCT00125749 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 1 intervention - of which Dendritic cell vaccination is the first listed.
NCT00125749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00125749 about?
NCT00125749 is a clinical study titled "Vaccination of Patients With Stage IV Melanoma With Dendritic Cells". The purpose of this study is to test a novel dendritic cell (DC) vaccine in patients with Stage IV melanoma.
What is the current status of trial NCT00125749?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2005-07. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00125749?
The interventions under investigation include: Dendritic cell vaccination (BIOLOGICAL).
Who is sponsoring clinical trial NCT00125749?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00125749's enrollment target sits among peer trials
30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia